You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Chemotherapy and other systemic treatment regimens may change due to COVID-19. Find out more at Systemic Treatment Regimens During COVID-19.

pemetrexed

( peh-meh-TREX-edd )
Funding:
New Drug Funding Program
  • Pemetrexed - Non-Small Cell Lung Cancer (Second or Subsequent Line)
  • Pemetrexed - Combination with Platinum for Non-Small Cell Lung Cancer
  • Pemetrexed - Non-Small Cell Lung Cancer (following Crizotinib)
  • Pemetrexed - Advanced Malignant Pleural Mesothelioma (MPM)
  • Pemetrexed - Maintenance Treatment of Nonsquamous Non-Small Cell Lung Cancer (NSCLC)
  • Pemetrexed - Adjuvant Treatment of Completely Resected Stage II or IIIA Non-Small Cell Lung Cancer
Other Name(s): Alimta®
Appearance: Colourless solution mixed into larger bags of fluids

You might also be interested in